Publications

from medical journals

  1. Hatzichristou, D. Beyond symptomatic treatment: PDE5 inhibitors as initiators, enablers, and sustainers of erectile function. Int J Impot Res (2026).
  1. Kaltsas A, Hatzichristou D. Erectile dysfunction and Peyronie’s disease: from biologics to nanomedicine-enabled therapies. Sex Med. 2026 Apr 16;14(3):qfag019.
  1. Hatzichristou, D. From fibrosis to restoration: the multimodal 3 Ts protocol for Peyronie’s disease. Int J Impot Res (2026).
  1. Pyrgidis N, Kalyvianakis D, Mykoniatis I, Hatzichristou D. Low-intensity shockwave therapy for erectile dysfunction due to diabetes mellitus or coronary artery disease: An individual participant data meta-analysis from a single center.Andrology. 2026 Feb;14(2):348-351.
  1. Pyrgidis N, Kalyvianakis D, Mykoniatis I, Hatzichristou D.
    The recommended treatment protocol for low-intensity shockwave therapy based on the severity of erectile dysfunction.
    Int J Impot Res. 2024.
  1. Kalyvianakis D, Mykoniatis I, Pyrgidis N, Kapoteli P, Zilotis F, Hatzichristou D.
    The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial. J Sex Med. 2024; 28;21(6):533-538.
  1. Dankova I, Pyrgidis N, Tishukov M, Georgiadou E, Nigdelis MP, Solomayer EF, Marcon J, Stief CG, Hatzichristou D.
    Efficacy and Safety of Platelet-Rich Plasma Injections for the Treatment of Female Sexual Dysfunction and Stress Urinary Incontinence: A Systematic Review. Biomedicines. 2023; 28;11(11):2919.
  1. Kalyvianakis D, Poulios E, Mykoniatis I, Pyrgidis N, Zilotis F, Hatzichristou D.
    Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Letter. J Urol. 2023; 210(5): 733-734.
  1. Poulios E, Mykoniatis I, Pyrgidis N, Kalyvianakis D, Hatzichristou D.
    Platelet-rich plasma for the treatment of erectile dysfunction: a systematic review of preclinical and clinical studies. Sex Med Rev. 2023; 27:11(4):359-368.
  1. Kalyvianakis D, Mykoniatis I, Pyrgidis N, Kapoteli P, Zilotis F, Fournaraki A, Hatzichristou D.
    The Effect of Low-Intensity Shock Wave Therapy on Moderate Erectile Dysfunction: A Double-Blind, Randomized, Sham-Controlled Clinical Trial. J Urol. 2022; 208(2):388-395.
  1. Mykoniatis I, Pyrgidis N, Zilotis F, Kapoteli P, Fournaraki A, Kalyvianakis D, Hatzichristou D.
    The Effect of Combination Treatment With Low-Intensity Shockwave Therapy and Tadalafil on Mild and Mild-To-Moderate Erectile Dysfunction: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. J Sex Med. 2022 Jan;19(1):106-115.
  1. Mykoniatis I, Kalyvianakis D, Kapoteli P, Zilotis F, Fournaraki A, Poulios E, Hatzichristou D.
     Can low intensity shockwave therapy match the efficacy of phosphodiesterase-5 inhibitors for erectile dysfunction treatment? A pooled data analysis from two randomized clinical trials. Int J Impot Res. 2021 Apr;33(3):383-385.
  1. Pyrgidis N, Mykoniatis I, Haidich AB, Tirta M, Talimtzi P, Kalyvianakis D, Ouranidis A, Hatzichristou D.
    Effect of phosphodiesterase-type 5 inhibitors on erectile function: an overview of systematic reviews and meta-analyses. BMJ Open. 2021 Aug 24;11(8):e047396.
  1. Mykoniatis I, Pyrgidis N, Sokolakis I, Ouranidis A, Sountoulides P, Haidich AB, van Renterghem K, Hatzichristodoulou G, Hatzichristou D.
    Assessment of Combination Therapies vs Monotherapy for Erectile Dysfunction: A Systematic Review and Meta-analysis. JAMA Netw Open. 2021 Feb 1;4(2):e2036337.
  1. Mykoniatis I, Kalyvianakis D, Zilotis F, Kapoteli P, Fournaraki A, Poulios E, Hatzichristou D.
    Evaluation of a low-intensity shockwave therapy for chronic prostatitis type IIIb/chronic pelvic pain syndrome: a double-blind randomized sham-controlled clinical trial. Prostate Cancer Prostatic Dis. 2021 Jun;24(2):370-379.
  1. Mykoniatis I, Pyrgidis N, Kalyvianakis D, Zilotis F, Kapoteli P, Fournaraki A, Hatzichristou D.
    Comparing two different low-intensity shockwave therapy frequency protocols for nonbacterial chronic prostatitis/chronic pelvic pain syndrome: A two-arm, parallel-group randomized controlled trial. Prostate. 2021 Jun;81(9):499-507.
  1. Mykoniatis I, Pyrgidis N, Sokolakis I, Sountoulides P, Hatzichristodoulou G, Apostolidis A, Hatzichristou D.
    Low-intensity shockwave therapy for the management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. BJU Int. 2021 Aug;128(2):144-152.
  1. Poulios E, Mykoniatis I, Pyrgidis N, Zilotis F, Kapoteli P, Kotsiris D, Kalyvianakis D, Hatzichristou D.
    Platelet-Rich Plasma (PRP) Improves Erectile Function: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. J Sex Med. 2021 May;18(5):926-935
  1. Kalyvianakis D, Mykoniatis I, Memmos E, Kapoteli P, Memmos D, Hatzichristou D.
    Low-intensity shockwave therapy (LiST) for erectile dysfunction: a randomized clinical trial assessing the impact of energy flux density (EFD) and frequency of sessions. Int J Impot Res. 2020 May;32(3):329-337.
  1. Sokolakis I, Dimitriadis F, Teo P, Hatzichristodoulou G, Hatzichristou D, Giuliano F.
    The Basic Science Behind Low-Intensity Extracorporeal Shockwave Therapy for Erectile Dysfunction: A Systematic Scoping Review of Pre-Clinical Studies. J Sex Med. 2019 Feb;16(2):168-194.
  1. Kalyvianakis D, Memmos D, Mykoniatis I, Kapoteli P, Hatzichristou D. Low-Intensity
    Shockwave Therapy (LiST) for Erectile Dysfunction: Is It Safe for Patients on Anticoagulant Medication? J Sex Med. 2019 Sep;16(9):1478-1480.
  1. Sokolakis I, Dimitriadis F, Psalla D, Karakiulakis G, Kalyvianakis D, Hatzichristou D.
    Effects of low-intensity shock wave therapy (LiST) on the erectile tissue of naturally aged rats. Int J Impot Res. 2019 May;31(3):162-169.
  1. Kalyvianakis D, Memmos E, Mykoniatis I, Kapoteli P, Memmos D, Hatzichristou D.
    Low-Intensity Shockwave Therapy for Erectile Dysfunction: A Randomized Clinical Trial Comparing 2 Treatment Protocols and the Impact of Repeating Treatment. J Sex Med. 2018 Mar;15(3):334-345.
  1. Kalyvianakis D, Hatzichristou D.
    Low-intensity Shockwave therapy improves hemodynamic parameters in patients with vasculogenic erectile dysfunction: a triplex Ultrasonography-based sham-controlled trial. J Sex Med 2017; 14(7): 891-897
  1. Hatzichristou D.
    Low-Intensity Extracorporeal Shock Waves Therapy (LI-ESWT) for the treatment of erectile dysfunction: Where do we stand? Eur Urol. 2017 Feb;71(2):234-236.
  1. Hatzichristou D, Kirana PS, Banner L, Althof SE, Lonnee-Hoffmann RA, Dennerstein L, Rosen RC.
    Diagnosing Sexual Dysfunction in Men and Women: Sexual History Taking and the Role of Symptom Scales and Questionnaires. J Sex Med. 2016 Aug;13(8):1166-82.
  1. Hatzichristou D, d’Anzeo G, Porst H, Buvat J, Henneges C, Rossi A, Hamidi K, Büttner H.
    Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities. BMC Urol. 2015 Nov 12;15:111.
  1. Hatzimouratidis K, Hatzichristou D. How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment. Curr Diab Rep. 2014;14(11):545
FIND US

12, Mackenzie King
Aghia Sophia Square
54622 Thessaloniki

CONTACT

T: 2311 261271
E: info@regenerativeclinic.gr

Copyright DVSDesign 2023. All Rights Reserved